Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Alan C. Dalkin"'
Autor:
William B. Horton, James T. Patrie, Maggie Graham, Alan C. Dalkin, Mark W. True, Lauren M Duhigg, Elaine Pelley
Publikováno v:
Journal of the Endocrine Society
BackgroundThe Endocrine Self-Assessment Program In-Training Examination (ESAP-ITE) has the novel formative approach of allowing open access to all questions and answers after secure examination administration is complete, resulting in the creation of
Autor:
Susan E. Kirk, Alan C. Dalkin, William B. Horton, Christian A. Chisholm, Zhenqi Liu, Luke Lancaster, Meaghan M Stumpf, Joseph D Coppock, Philip W. Smith
Publikováno v:
Journal of the Endocrine Society
Gestational primary hyperparathyroidism (GPHPT) is a rare condition with fewer than 200 cases reported. We present the case of a 21-year-old woman who presented at 10 weeks’ gestation with severe hypercalcemia. Laboratory investigation was consiste
Publikováno v:
Clinical Spine Surgery: A Spine Publication. 29:134-140
Over 50 million Americans have low bone mass. Poor bone quality is known to complicate spinal fusion surgery, which relies on strong bony purchase to be effective. Unfortunately, many spine surgeons do not perform routine workups for either osteoporo
Autor:
Todd E. Abbott, Alan C. Dalkin, Jane Bennett-Wick, Henry F. Frierson, Maria Luisa C. Policarpio-Nicolas
Publikováno v:
Diagnostic Cytopathology. 36:115-119
Oncogenic (tumor-induced) osteomalacia is a rare paraneoplastic syndrome of phosphate wasting that is frequently associated with phosphaturic mesenchymal tumor (PMT). As the cytologic features of this tumor apparently have not been reported, we descr
Autor:
Alan C. Dalkin, JoAnn V. Pinkerton
Publikováno v:
American Journal of Obstetrics and Gynecology. 197:559-565
Combination therapy for osteoporosis has been tested in small trials of short duration with various combinations. Pertinent human and animal randomized clinical trial data were identified through Medline and reviewed with a focus on the risks and ben
Publikováno v:
Endocrine. 29:399-404
This study investigated FSHbeta transcriptional responses to the suppression of endogenous follistatin (FST) production using FST antisense RNA (FST-AS) expressing adenovirus constructs in female rat pituitary cells in vitro. Adenoviral delivery syst
Publikováno v:
Biology of Reproduction. 73:491-499
The neuropeptide pituitary adenylate cyclase activating polypeptide (ADCYAP 1, or PACAP) has been demonstrated to enhance gonadotropin-releasing hormone (GnRH)-induced gonadotropin secretion and regulate gonadotropin subunit gene expression in cultur
Autor:
Kevin W. Aylor, Alan C. Dalkin, John C. Marshall, Daniel J. Haisenleder, Margaret A. Shupnik, Laura L. Burger, Heidi E. Walsh
Publikováno v:
Biology of Reproduction. 72:523-529
This study investigated whether estradiol (E2) or testosterone (T) activate extracellular signal-regulated kinase (ERK) and calcium/calmodulin-dependent kinase II (Ca/CaMK II), as indicated by enzyme phosphorylation in rat pituitaries. In vivo studie
Pituitary Follistatin Gene Expression in Female Rats: Evidence That Inhibin Regulates Transcription1
Autor:
Kevin W. Aylor, Alan C. Dalkin, Daniel J. Haisenleder, John C. Marshall, Kathleen A. Prendergast, Laura L. Burger
Publikováno v:
Biology of Reproduction. 70:364-370
Follistatin (FS), along with the members of the transforming growth factor b family activin and inhibin, are important regulators of FSH secretion and messenger RNA production. While activin and inhibin appear to function as tonic modulators of FSH (
Autor:
Daniel J. Haisenleder, Kathleen A. Prendergast, Kevin W. Aylor, Laura L. Burger, Alan C. Dalkin, John C. Marshall
Publikováno v:
Endocrinology. 145:71-78
The gonadotropin beta-subunit mRNAs are differentially regulated by androgens. Testosterone (T) suppresses LH-beta and increases FSH-beta. We aimed to determine whether androgens regulate LH-beta and FSH-beta transcription [as measured by changes in